FDA
approval
· 2020-08-31
FDA Approved: BLISOVI FE 1/20 — Supplemental Application (Lupin Pharmaceuticals, Inc.)
Summary
FDA approved Lupin's supplemental application for BLISOVI FE 1/20, adding a 1/20 strength of the combined oral contraceptive norethindrone acetate and ethinyl e…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BLISOVI FE 1/20 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)